课题基金 / 基金详情

LENTIVIRAL VECTOR FOR GENE TRANSFER TO HEMATOPOIETIC STEM CELLS

LENTIVIRAL VECTOR FOR GENE TRANSFER TO HEMATOPOIETIC STEM CELLS
用于基因转移至造血干细胞的慢病毒载体
批准号：
7958998
负责人：
Donald B Kohn
金额：
$14.23万
依托单位：
UNIVERSITY OF CALIFORNIA AT DAVIS
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-05-01 至 2010-04-30
来源：
https://reporter.nih.gov/project-details/7958998
关键词：
AutologousBehavior TherapyBone Marrow TransplantationBusulfanCaliforniaComputer Retrieval of Information on Scientific Projects DatabaseFundingGene TransferGrantHematopoietic stem cellsHumanInstitutionLentivirus VectorPrimatesResearchResearch PersonnelResourcesSourceStem cellsTransplantationUnited States National Institutes of Healthconditioningcytotoxic

项目摘要

项目成果

Donald B Kohn的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这些研究主要集中在自体转导的造血干细胞移植的条件性治疗(白头翁)。白花丹会产生早期干细胞的特异性损失，并在人类骨髓移植之前被用作干细胞细胞毒调节剂。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. These studies focus on conditioning therapy (busulfan) for transplant of autologous transduced hematopoietic stem cells. Busulfan produces a specific loss of early stem cells and has been used as a stem cell cytotoxic conditioning agent prior to bone marrow transplantation in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFS-ADA Lentiviral Vector Transduction of Bone Marrow CD34+ Cells for ADA-SCID
EFS-ADA Lentiviral Vector Transduction of Bone Marrow CD34+ Cells for ADA-SCID
EFS-ADA Lentiviral Vector Transduction of Bone Marrow CD34+ Cells for ADA-SCID
EFS-ADA Lentiviral Vector Transduction of Bone Marrow CD34+ Cells for ADA-SCID
海外基金